1022087

Dr. Reginald Sampson — FEI 3013740382

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 18, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Lancaster, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
753021 CFR 312.62(b)Case history records- inadequate or inadequate